Gallwitz, B <br/><br/>
[New antihyperglycemic drugs. Examination of cardiovascular outcomes with alogliptin versus standard of care (EXAMINE) and saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI 53)].  [electronic resource] 

 -  Der Internist  Jul 2014 
 - 859-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1432-1289 
<br/><br/><label>Standard No.: </label>10.1007/s00108-014-3523-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--analogs & derivatives<br/>Angina, Unstable--drug therapy<br/>Cardiovascular Diseases--epidemiology<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptides--therapeutic use<br/>Dipeptidyl-Peptidase IV Inhibitors--therapeutic use<br/>Female<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Male<br/>Myocardial Infarction--drug therapy<br/>Piperidines--therapeutic use<br/>Uracil--analogs & derivatives